OPDM4_RILPL1

Gene
RILPL1
Disease
OPDM4
Inheritance
AD
Classification
Moderate
Total Score
10
Publications Reviewed
3
Publication Span
2.05 years
Last Updated
08/14/2025
Curator(s)
Macayla Weiner, Laurel Hiatt

Description

A CGG/GGC repeat expansion in the 5′ UTR/promoter region of RILPL1 is associated with autosomal dominant oculopharyngodistal myopathy type 4 (OPDM4). Uploaded sources report RILPL1 expansions in multiple affected individuals, including cohort-level evidence of 11 OPDM4 individuals, with pathogenic repeat sizes around 135–197 repeats and much smaller repeat ranges in controls. Supporting evidence includes linkage/co-segregation in OPDM4 families, patient muscle pathology with rimmed vacuoles and p62-positive intranuclear inclusions, repeat-containing RNA foci with RNA-binding protein/p62 co-localization, and polyG/p62 co-localization in patient muscle. Regulatory studies show locus methylation/transcriptional context and bidirectional transcription across the repeat, but no consistent change in RILPL1 mRNA or protein levels in OPDM4 muscle.

Genetic evidence

Total: 7.5

Singular EvidenceProbandsPMID:379233806In a 94-case Chinese OPDM cohort, 11 individuals were reported with RILPL1 CGG/GGC repeat expansions (OPDM4) after screening known OPDM repeat loci; the paper provides cohort-level support rather than detailed new RILPL1 proband descriptions.
Collective EvidenceSegregationPMID:357001201.5Parametric linkage analysis in Family 1 mapped disease to 12q24.3 with a maximum LOD score of 2.4007; RILPL1 GGC expansion was identified within the linked interval, tracked with affected relatives, and shared haplotype data supported a founder effect across families.
2 rows

Experimental evidence

Total: 2.5

FunctionProtein interactionPMID:351488301In OPDM4 patient muscle, immunofluorescence showed glycine/polyG signal co-localized with p62 in intranuclear inclusions, consistent with repeat-associated polyG protein aggregation; the paper also notes gene-level RILPL1/RAB10 interaction biology.
FunctionRegulatory impactPMID:357001200.5Targeted methylation showed hypermethylation at the RILPL1 locus in unaffected ultralong expansion carriers, while OPDM4 patient muscle showed no significant RILPL1 mRNA or protein change; CAGE-seq and strand-specific RNA-seq supported alternative/antisense TSSs and bidirectional transcription across the repeat locus.
Functional AlterationPatient cellsPMID:351488301Patient muscle biopsies showed rimmed vacuoles and intranuclear filamentous inclusions; RNA FISH/immunofluorescence showed expanded RILPL1 RNA foci co-localized with MBNL1 and p62 in intranuclear inclusions in OPDM4 muscle but not control muscle.
3 rows

Note: Maximum score caps apply at evidence type, category, and supercategory levels, so section totals may be lower than the raw sum of row scores.